<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02104297</url>
  </required_header>
  <id_info>
    <org_study_id>Agitation</org_study_id>
    <nct_id>NCT02104297</nct_id>
  </id_info>
  <brief_title>Effect of Deksmedetomidine and Remifentanil in Extubation Agitation</brief_title>
  <acronym>EA</acronym>
  <official_title>The Effect of Deksmedetomidin and Remifentanil Infusion on Extubation Agitation and Recovery Conditions on Nasal Septoplasty Operation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Diskapi Yildirim Beyazit Education and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Diskapi Yildirim Beyazit Education and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the effect of two different agents deksmedetomidine, remifentanil and placebo,
      agitation and recovery condition, on nasal septum operation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Nasal septum operation cause agitation because of nasal package. This research aims determine
      which agent , deksmedetomidine remifentanil or placebo, is more beneficial to the patient.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To asses postoperative agitation score by Riker sedation agitation scale</measure>
    <time_frame>Postoperative first hour</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Yo asses postoperative side effects emesis, vomitting or pain</measure>
    <time_frame>Postoperative first hour</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Agitation</condition>
  <arm_group>
    <arm_group_label>Deksmedetomidine infusion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>To prevent agitation deksmedetomidine infused during operation and at the end of surgery agitation scor measured by Riker sedation agitation scale.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Remifentanil infusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>To prevent agitation remifentanil infused during operation at the end of surgery agitation scor measured by Riker sedation agitation scale.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline infusion</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Saline infused during operation and at the end of surgery agitation scor measured by Riker sedation agitation scale.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>deksmedetomidine</intervention_name>
    <description>deksmedetomidine infused during operation 0.2 mcg/kg/hour</description>
    <arm_group_label>Deksmedetomidine infusion</arm_group_label>
    <other_name>Precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil</intervention_name>
    <description>Remifentanil infused during operation 0.2 mcg/kg/min</description>
    <arm_group_label>Remifentanil infusion</arm_group_label>
    <other_name>Ultiva</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>During operation saline infused equal vol√ºme of deksmedetomidine and remifentanil</description>
    <arm_group_label>Saline infusion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients

        Exclusion Criteria:

          -  patients with any sensitivity each drug
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Reyhan Polat, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yildirim Beyazit Education and Research Hospita</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Reyhan Polat, MD</last_name>
    <phone>+905326734310</phone>
    <email>reyhanp9@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Reyhan Polat</name>
      <address>
        <city>Ankara</city>
        <zip>06610</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Reyhan Polat, MD</last_name>
      <phone>+905326734310</phone>
      <email>reyhanp9@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Reyhan Polat, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 2, 2014</study_first_submitted>
  <study_first_submitted_qc>April 3, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 4, 2014</study_first_posted>
  <last_update_submitted>April 3, 2014</last_update_submitted>
  <last_update_submitted_qc>April 3, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 4, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Diskapi Yildirim Beyazit Education and Research Hospital</investigator_affiliation>
    <investigator_full_name>Reyhan Polat</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <keyword>Nasal septum operation</keyword>
  <keyword>agitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psychomotor Agitation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Remifentanil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

